ctrl K

Lipella Pharmaceuticals I... (LIPO)

NASDAQ: LIPO · Real-Time Price · USD

2.50

-0.13 (-5.12%)

At close: Apr 29, 2025, 3:59 PM

Lipella Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2.18M	3.29M	5.12M	1.41M	606.74K	26K
Short-Term Investments	n/a	n/a	n/a	300.55K	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	-150.82K	-204.8K	-255.59K	n/a
Receivables	84.71K	32.29K	113.66K	n/a	69.03K	83.89K
Inventory	n/a	n/a	-113.66K	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a	n/a	83.89K
Total Current Assets	2.62M	3.43M	5.8M	1.81M	699.43K	118.92K
Property-Plant & Equipment	56.62K	147.89K	150.82K	204.8K	255.59K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	56.62K	147.89K	150.82K	204.8K	255.59K	n/a
Total Assets	2.67M	3.58M	5.95M	2.01M	955.02K	118.92K
Account Payables	388.19K	138.02K	384.36K	46.9K	24.54K	49.34K
Deferred Revenue	n/a	n/a	n/a	178.97K	24.99K	n/a
Short-Term Debt	n/a	n/a	275K	25K	82.04K	50K
Other Current Liabilities	n/a	n/a	n/a	-357.93K	-24.99K	n/a
Total Current Liabilities	754.42K	385.36K	1.18M	340.63K	207.77K	165.67K
Long-Term Debt	n/a	n/a	n/a	50K	50K	50K
Other Long-Term Liabilities	n/a	n/a	n/a	30.35K	25.97K	21.59K
Total Long-Term Liabilities	n/a	47.37K	96.26K	248.71K	283.94K	71.59K
Total Liabilities	754.42K	432.73K	1.27M	589.34K	491.7K	237.26K
Total Debt	47.6K	136.59K	429.52K	282.96K	388.91K	100K
Common Stock	121.00	605.00	574.00	967.00	574.00	520.00
Retained Earnings	-15.34M	-10.32M	-5.7M	-3.11M	-1.24M	-1.18M
Comprehensive Income	n/a	n/a	n/a	-3.11M	-1.24M	-1.18M
Shareholders Equity	1.92M	3.14M	4.68M	1.42M	463.32K	-118.34K
Total Investments	n/a	n/a	n/a	300.55K	n/a	n/a